Three Studies Support Medtronic’s Cryoablation Systems As ‘First Line’ AFib Treatment

Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.

MEDTRONIC'S ARCTIC FRONT ADVANCE CRYOBALLOON • Source: Medtronic PLC

Results of three different trials showed pulmonary vein isolation ablation with Medtronic’s Arctic Front Advance cardiac cryoballoon is a safe and effective “first line” option for patients with atrial fibrillation, even if they have not already tried drug therapy.

The company hopes the results of these trials will lead the US Food and Drug Administration to expand the approved...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D